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Abstract 
Porphyromonas endodontalis is a black pigmented Gram-negative 
organism that has been identified as a common pathogen of the necrotic 
root space and within endodontic periapical lesions. P. endodontalis 
synthesizes several classes of complex biologically active lipids, which 
may promote osteoclastogenesis and osteoclast activation. Specifically, in 
teeth with necrotic pulps P. endodontalis Lipid 654 of the serine lipid class 
has been shown to activate pathways that could lead to apical bone 
destruction. Phylogenetically related Porphyromonas gingivalis 
synthesizes structurally identical Lipid 654. Objectives: The first purpose 
of this study is to isolate P. gingivalis Lipid 654 and examine the capacity 
of common intracanal irrigants and medicaments to remove this lipid class 
from mineralized discs. The second purpose of this study is to evaluate 
the capacity of common endodontic intracanal irrigants and medicaments 
to degrade Lipid 654 to breakdown product Lipid 430. Methods: P. 
gingivalis (ATCC #33277, type strain) was grown under anaerobic 
conditions and centrifuged. P. gingivalis total lipids were recovered using 
the Bligh and Dyer phospholipid extraction procedure and were 
fractionated by semipreparative normal phase HPLC. A known amount of 
isolated P. gingivalis Lipid 654 was applied to bovine dentin discs and 
exposed to 0.5% NaOCl, 5.25% NaOCl, calcium hydroxide in saturated 
solution, and sterile water for 1 minute, 15 minutes, or 1 week. Removal of 
Lipid 654 and degradation of Lipid 654 to Lipid 430 was assessed by 
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mass spectrometric analysis. Results: Lipid extraction and MS analysis 
revealed that 1 and 15 minute exposures of NaOCl at 0.5% and 5.25% 
and 1 week calcium hydroxide treatment can remove Lipid 654 from 
bovine dentin discs. One week calcium hydroxide treatment can hydrolyze 
Lipid 654 into the Lipid 430 form. Conclusions: Our results show that P. 
gingivalis Lipid 654 can be removed from bovine dentin discs and 
hydrolyzed into the Lipid 430 form by common endodontic irrigants and 
medicaments.  
 
 
 
 v 
 
Introduction: 
 
Apical periodontitis manifests as bone destruction caused by host 
response to microorganisms and microbial byproducts in the necrotic root canal 
system [1]. Porphyromonas endodontalis is a Gram negative pathogen 
commonly found in necrotic root canals and apical lesions related to primary and 
secondary endodontic infections [2-4]. The involvement of P. endodontalis in the 
progression of apical periodontitis is believed to be related to release of 
destructive byproducts, which activate innate host cell response pathways [5]. 
Serine lipids of P. endodontalis, specifically the Lipid 654 and Lipid 430 classes 
are biologically active complex lipids that are identical in structure to those lipid 
classes produced by Porphyromonas gingivalis [6]. Our unpublished data 
suggest the activity of these lipids may play a role in both the bone and soft 
tissue destruction that is associated with apical periodontitis in humans. 
The goal of endodontic therapy is to eradicate microbial irritants and 
proinflammatory substances from the root canal system and to obturate the 
cleaned and shaped root canal space to prevent future recontamination. This is 
accomplished through a combination of mechanical instrumentation of canal 
walls and irrigation with antimicrobial substances to remove and destroy irritants 
within the canal [7]. Sodium hypochlorite (NaOCl) is perhaps the most effective 
irrigant due to its bactericidal effect on endodontic pathogens including 
vegetative bacteria, spore-forming bacteria, fungi, protozoa, and viruses [8], its 
tissue dissolution capacity, and its ability to remove organic components of the 
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smear layer [9].  NaOCl acts by disrupting oxidative phosphorylation and DNA 
synthesis in bacterial cells and has been shown to be effective in root canal 
disinfection at concentrations of 0.5% to full strength at 5.25% [10]. Calcium 
hydroxide is an intracanal medicament used for root canal disinfection by 
creating an alkaline environment through release of calcium and hydroxyl ions 
over time [11]. Calcium hydroxide is slow acting and has been shown to be 
significantly more effective when exposed for a duration of 7 days versus 10 
minutes [12]. It has been previously shown to have tissue dissolving capacity and 
to specifically suppress apical bone destruction by attenuating the virulence of P. 
endodontalis LPS [13].  
Examination of P. endodontalis Lipid 654 or Porphyromonas gingivalis  Lipid 
654 removal or degradation by these common endodontic antimicrobial agents 
has not occurred. We hypothesize that sodium hypochlorite at two concentrations 
and calcium hydroxide will remove P. gingivalis Lipid 654 from bovine dentin 
discs and degrade P. gingivalis Lipid 654 to the Lipid 430 form.   
 2 
Specific Aims:  
 
The specific aims of this study are: 
 
1. Isolate P. gingivalis Lipid 654 
 
2. Determine the capacity of common endodontic irrigants and medicaments 
to remove Lipid 654 from mineralized surfaces of bovine dentin discs.  A 
predetermined amount of Lipid 654 will be adsorbed to a mineralized 
dentin disc surface. The surface will be exposed to the indicated intracanal 
irrigants and medicaments, then the remaining bacterial lipid on the discs 
will be quantified.  All experimental groups will be exposed for short time 
intervals of 1 and 15 minutes and calcium hydroxide will also be exposed 
for 1 week at physiological temperature. The mineralized bovine dentin 
discs will be acidified with 1% acetic acid and residual lipids will be 
extracted into chloroform and quantified by mass spectrometry. This 
experiment will demonstrate the capacity for endodontic intracanal 
irrigants and medicaments to remove adsorbed bacterial Lipid 654 from 
mineralized surfaces.   
 
3. Determine the capability of common endodontic irrigants and 
medicaments to degrade P. gingivalis Lipid 654 to the Lipid 430 class. 
Samples will be treated as stated above. The rate of degradation is 
determined by measuring the presence of Lipid 654 breakdown product, 
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Lipid 430 and the ratio between the amount of recovered lipid from each of 
the two lipid classes.   
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Background Information: 
The role of bacteria and bacterial byproducts in the progression of pulpal 
disease and apical periodontitis has been demonstrated in classic studies and is 
well accepted [14, 15]. Microorganisms and their byproducts have the ability to 
mediate changes in the dentin and pulp, which initiate pulpal inflammation and 
can lead to pulp necrosis and periapical lesion development [16]. Bone is in a 
continuous process of remodeling through osteoclast resorption and deposition 
by osteoblasts. As pulpal necrosis progresses to periapical disease, this 
homeostasis is disturbed resulting in periapical bone destruction through 
activation of osteoclast mediated bone resorption and inhibition of new bone 
formation [17].  
The human immune response is divided into innate immunity and adaptive 
immunity. Innate immunity consists of nonspecific defense mechanisms that 
react immediately to foreign antigens. These defense mechanisms include 
physical epithelial barriers, phagocytic leukocytes, dendritic cells, natural killer 
cells, and circulating plasma proteins. Adaptive immunity is an antigen-specific 
immune response developed over a longer period of time and is less involved in 
initial pulpal defense against pathogens. It becomes activated when the innate 
immune system is not able to eliminate an infection. Humoral immunity is 
adaptive immunity mediated by antibodies produced by B lymphocytes and cell-
mediated immunity is adaptive immunity mediated by T lymphocytes [18].  
The microorganisms found in primary root canal infections are typically 
dominated by Gram negative and obligatory anaerobic bacteria [2]. Specific 
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byproducts of Gram negative bacteria within the necrotic root canal system have 
been identified as promoters of inflammation and periapical tissue pathogenesis. 
Lipopolysaccharide (LPS) is the primary component of the outer membrane of all 
Gram negative bacteria and plays an important role in stimulating secretion of 
pro-inflammatory cytokines. It is composed of polysaccharides, fatty acids, and 
phosphate and is highly recognized as a virulence factor in the destruction of 
periapical tissues [19]. Lipid A is the moiety of LPS responsible for its toxicity. It 
interacts with macrophages and monocytes to elicit a strong host immune 
response. However, LPS is not inherently destructive. It stimulates competent 
cells like macrophages, neutrophils, and fibroblasts to release damaging 
chemical mediators such as tumor necrosis factor, interleukin (IL)-1, IL-5, IL-8, 
alpha-interferon, and prostaglandins that in turn initiate the host response [20].  
LPS maintains its virulence after cell death [21]. LPS freed from microorganisms, 
due to multiplication or cell death, binds to mineralized tissues and inhibits 
osteoblast differentiation and mineralization of bone [13].  
At the onset of microbial insult and pulpal inflammation, the number of 
antigen presenting cells of the innate immune system rapidly increases at the site 
of tissue injury [22]. Toll-like receptors (TLRs) are a family of pattern recognition 
receptors (PRRs) that are involved in pathogen detection. TLRs are 
transmembrane proteins found on antigen presenting cells as well as many other 
cell types, and play an important role in the recognition of microbial products.  
TLRs recognize pathogen-associated molecular patterns (PAMPs) on invading 
organisms, which are molecular pattern receptors that are evolutionarily 
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conserved from insects to humans [23]. Activation of TLRs initiates complex 
intracellular signaling cascades. As TLRs engage with their respective PAMPs, 
co-stimulatory molecules are expressed and secretion of pro-inflammatory 
cytokines is induced [24]. Ten human and twelve mouse TLRs have been 
identified to date. Toll-like Receptor 2 (TLR2) has been found in both human and 
mouse cellular plasma membrane and reacts with multiple microbial ligands 
including lipoteichoic acid, lipoproteins, and peptidoglycan, and human and 
mouse Toll-like Receptor 4 (TLR4) is known to respond to LPS [25]. Previous 
studies have associated TLR2 and TLR4 activity with periodontal inflammation 
and the Gram negative periodontal pathogen, P. gingivalis has been shown to 
signal via TLR2 and TLR4 [26-28]. Pro-inflammatory cytokines produced via 
TLR2 activation cause damage and bone loss in associated alveolar bone, as 
shown in studies using TLR2 knockout mice [29]. 
Several classes of biologically active complex lipids, distinct from Lipid A, 
are produced by P. gingivalis and P. endodontalis. These lipids can act as 
virulence factors. Specifically, the serine lipids have been shown to engage 
human and mouse TLR2. This activates the innate immune system and likely 
plays a role in mediating inflammatory responses. Clark et al. identified two 
serine lipid classes from P. gingivalis that act as TLR2 ligands [30]. In a mass 
spectrometry assessment, 654, 640, and 626 m/z negative ions make up the 
Lipid 654 class, referred to collectively as Lipid 654 (Figure 1) and the 430, 416, 
and 402 m/z negative ions make up the Lipid 430 class, referred to collectively as 
Lipid 430 (Figure 2).  
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Figure 1. Mass spectrometry of Lipid 654 with peaks representing m/z 654, 640, 
and 626 negative ions.  
 
 
  
Figure 2. Mass spectrometry of Lipid 430 with peaks representing m/z 430, 416, 
and 402 negative ions.  
 
 
The Lipid 430 class is the deesterified or nonesterified form of the Lipid 654 
class. It is thought to be a breakdown product of Lipid 654 and is isolated in far 
less abundance from P. gingivalis than Lipid 654. Both lipid classes are made up 
of identical amino acid base structures, however Lipid 654 contains an ester-
linked fatty acid where Lipid 430 does not [30]. Due to this physical difference, 
Lipid 430 is soluble in neutral or basic aqueous environments and Lipid 654 is 
not water soluble unless sonicated [30]. Another important distinction between 
the Lipid 654 and Lipid 430 involves their biologic activity. Lipid 430 has been 
shown to inhibit osteoblast differentiation at doses that are 4 to 10 times lower 
than Lipid 654. However, in comparison to Lipid 654, Lipid 430 is a weak 
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activator of TLR2 [Wang et al., submitted].  These lipid classes are structurally 
distinct from LPS Lipid A when assessed via mass spectrometric/nuclear 
magnetic resonance spectroscopy.  
The serine lipids produced by P. gingivalis have been shown to be 
identical in structure and have consistent MS/MS spectra to those produced by 
phylogenetically related P. endodontalis [6]. Porphyromonas endodontalis is a 
Gram negative pathogen commonly found in root canals and apical lesions 
related to primary and secondary endodontic infections [2-4, 16]. The structure of 
P. endodontalis Lipid 654 is shown in Figure 3. It contains two fatty acids: 3-
hydroxy iso C17:0 is amide linked to glycine and iso C15:0 is held in ester 
linkage by a β carbon of 3-hydroxy iso C17:0. The dipeptide head group is 
composed of glycine and a terminal serine. The similar structure of Lipid 430 is 
shown below in Figure 4.  
 
Figure 3. Structure of Lipid 654 
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Figure 4. Structure of Lipid 430 
 
Bacterial lipids from cell walls of Bacteroidetes species like P. gingivalis and P. 
endodontalis are present in all teeth with pulpal necrosis and apical periodontal 
lesions [31]. 
The goal of endodontic therapy is to eradicate microbial irritants and 
proinflammatory substances from the root canal system and to obturate the 
cleaned and shaped root canal space to prevent future recontamination. 
Complete cleaning and disinfection is not possible through mechanical means 
alone due to irregularly shaped and branching root canal systems with unique 
isthmuses and ramifications [32]. These mechanically inaccessible areas may 
house bacteria and bacterial byproducts, allowing for the possibility of 
resurgence of infection. The persistence of microorganisms in the root canal 
space after mechanical debridement is the main cause of endodontic treatment 
failure [33]. Because bacterial lipids found in the necrotic pulp space trigger 
inflammation independently of bacterial cell viability, removing and degrading 
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these residual lipids in addition to killing bacteria, may facilitate healing. Chemical 
means are used to further decontaminate these mechanically inaccessible areas 
of the irregular root canal system. Torabinejad et al. described the properties of 
the ideal root canal irrigant or medicament as one that completely removes the 
smear layer, penetrates into dentinal tubules, disinfects dentinal tubules, has 
sustained antibacterial action after use, has no negative impact on physical 
properties of dentin, does not interfere with sealing ability of restorative materials, 
does not discolor the tooth, is inexpensive, is convenient to use, and is 
nonantigenic, nontoxic, and noncarcinogenic to local tissue [34]. Haapasalo later 
added that an ideal irrigant should have a washing action, reduce friction, 
improve cutting of dentin by instruments, control temperature, dissolve organic 
and inorganic matter, penetrate deep within the root canal system, kill both 
planktonic and biofilm microbes, and detach biofilms [35]. The irrigant should 
also have low surface tension for flow into areas that are difficult or impossible to 
access mechanically, dissolve soft tissue for ease of removal in those areas 
instruments cannot reach, and act as a lubricant during mechanical 
instrumentation [36].  
 Many different irrigants and medicaments have been tried over the years 
in an effort to destroy and remove bacteria and bacterial byproducts from the 
necrotic root canal system. Everything from inert saline to highly toxic substances 
like formaldehyde have been used historically in endodontics. Several of these 
substances have fallen out of favor due to toxicity, limited effectiveness, and 
other qualities that make them less than ideal compared to the irrigants and 
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medicaments commonly used today. For example, Grossman advocated the use 
of antibiotic root canal dressing in the 1940s and early 1950s, but this practice 
was no longer advised by the late 1950s due to concerns over allergy and 
antibiotic resistance [37, 38]. Here, we will review some of the key historic 
endodontic irrigants and medicaments.  
Chloramines are produced by reaction of hypochlorous acid (HOCl) and 
an amine, amide, or imide and slowly release chlorine. There are several 
chloramines, but chloramine T has been historically used as an endodontic 
irrigant. Chloramine T is a chlorine-releasing compound of sodium p-toluene 
sulfonchloramide that is formed by combining sodium 4-toluene sulfonamide and 
HOCl. It is water soluble up to 12% and hydrolyzes to form HOCl [39]. It is 
effective against algae, bacteria, viruses, fungi, and mycobacteria. The method of 
action involves interference with bacterial metabolism and destruction of DNA by 
oxidation. It’s use was first reported in 1916 by Dakin et al. as a disinfectant to 
treat necrotic tissue wounds during World War I [40]. Austin and Taylor published 
multiple reports on the disinfection properties of chloramine T in 1918. They 
described chloramine T as a non-irritating antiseptic with “detoxicating action”, 
but found it did not have the capacity to dissolve necrotic tissue [41-44]. Later 
studies described the slow bactericidal action of chloramine T dependent on pH, 
temperature, and concentration. The antibacterial properties decrease as pH 
increases, making its practical use best in acidic environments with long 
exposure time [39, 45]. Chloramine T is no longer recommended for use in 
endodontics because its effectiveness and ease of use do not surpass the more 
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modern irrigants typically used today. 
Quaternary ammonium compounds are bactericidal cationic surface-active 
agents that alter the permeability of the bacterial cell membrane. These 
surfactants interfere with membrane lipid bilayer integrity, interrupt transduction, 
disrupt membrane barrier function, impede action of membrane proteins, and 
ultimately interfere with growth and viability of microorganisms [46]. They have 
been considered suitable nonspecific root canal irrigants due to their activity 
against Gram positive and Gram negative organisms and fungi [47]. In the 1950s 
Strindberg was the first to recommend the use of quaternary ammonium 
compounds in endodontics after favorably comparing brand name Biosept with 
the more toxic and corrosive sulfuric acid [48]. Salvizol and Solvidont are two 
brand names of quaternary ammonium compounds with the active ingredient bis-
dequalinium acetate that have been used as root canal disinfecting irrigants more 
recently. Their desirable properties include low tissue toxicity, low surface tension 
for good flow, and the ability to remove the smear layer as well as or better than 
ethylenediaminetetraacetic acid (EDTA) [47, 49, 50]. The bactericidal action of 
quaternary ammonium compounds has been demonstrated in numerous studies 
[51-53]. However, many studies also exist questioning clinical safety and ability 
of these irrigants to remove debris [51, 54-56]. Haikel et al. showed Salvizol only 
desorbed 2% of protein albumin from apatite surfaces in comparison to 30-70% 
for NaOCl at concentrations of 0.5% to 6% [56] and Engstrom and Spangberg 
found 1% Biosept was toxic to HeLa cells and recommended against its use 
clinically in 1969 [51]. Cetrimide is a bactericidal cationic surfactant containing a 
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mixture of quaternary ammonium salts that has been shown to decrease 
mechanical stability within bacterial biofilms and eradicate Enterococcus faecalis 
in vitro. It is utilized most commonly as an adjunct to other irrigants such as 
chlorhexidine, EDTA, citric acid, MTAD, and tetraclean to enhance their desirable 
properties [57-59]. Cetrimide is not commonly used in standard endodontic 
irrigation protocols, but research from the last five years shows favorable results. 
An in vitro study by Kaushik et al. found exposure to 0.2% cetrimide alone 
caused maximum reduction in levels of E. faecalis compared to 5.25% NaOCl, 
3% hydrogen peroxide, 10% citric acid, and 17% EDTA [60]. However, 
quaternary ammonium compounds in general should be used with caution 
clinically due to high allergenic potential [61]. 
Hydrogen peroxide (H2O2) was discovered in 1818 by Louis Jacques 
Thenard and first produced in a pure form through vacuum distillation in 1894 by 
Richard Wolffenstein [62]. In 1915 Dakin described H2O2 as a mildly effective 
antiseptic [63]. It is an oxidizing agent active against bacteria, yeast, fungi, 
spores, and viruses through production of hydroxyl radicals which cause cell 
death by interfering with macromolecules including proteins, membrane lipids, 
and DNA [41, 64]. Hydrogen peroxide has been used as a bactericidal 
endodontic irrigant in concentrations of 1% to 30%, but primarily at a 
concentration of 3%. It has also been shown to physically dislodge necrotic 
tissue and dentin debris [65], but does not have the capacity to dissolve tissue. In 
the past, H2O2 has been used as an adjunct in repeated alternation with sodium 
hypochlorite to achieve both tissue removal and dissolution, but studies have 
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shown the alternating use of 2% or 5% sodium hypochlorite with 3% H2O2 was 
less effective at dissolving necrotic tissue than NaOCl alone [66]. It has also 
been shown that the combination of H2O2 with sodium hypochlorite was not 
significantly better at destroying E. faecalis than irrigation with sodium 
hypochlorite alone [67]. The use of H2O2 as an endodontic irrigant is not currently 
recommended because it has not been shown to dissolve tissue, increase 
removal of intracanal debris, or reduce bacterial load within the root canal as 
effectively as more widely used alternatives such as varying concentrations of 
NaOCl [64].   
Sodium hypochlorite is the most important endodontic irrigant used today. 
In water it ionizes into sodium and hypochlorite ions to form equilibrium with 
HOCl. NaOCl is most effective against microbiota in environments with low to 
neutral pH, where most of the chlorine exists as HOCl [35]. It acts by disrupting 
oxidative phosphorylation and DNA synthesis in bacterial cells. The antibacterial 
efficacy of NaOCl is concentration dependent [68], but it has been shown to be 
effective in root canal disinfection from 0.5% to full strength at 5.25% [10]. It has 
a wide-spectrum and is nonspecific, killing bacteria, spores, and viruses [9]. 
NaOCl is inexpensive, easy to store, and widely available. Sodium hydroxide is 
added to commercially available bleach solutions to increase the pH and ensure 
stability of the solution. Household bleach usually contains 0.01-0.05% sodium 
hydroxide to slow decomposition of sodium hypochlorite into sodium chloride and 
sodium chlorate. NaOCl was first recommended as a bleaching agent in the late 
1700s and Labarraque recommended its use to prevent infectious diseases at 
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the turn of the nineteenth century [9]. Its bactericidal action has been reported 
since the early 1900s. First, by Dakin as an antimicrobial wash to treat necrotic 
tissue in soldiers’ open wounds in World War I, then in multiple studies by Austin 
and Taylor [41-44, 63, 69]. Crane was the first to suggest NaOCl for use as and 
endodontic irrigant in 1920 [70]. NaOCl dissolves essentially all exposed organic 
matter within the root canal in a concentration dependent manner [71, 72]. 
Clinically, it has a very low allergenic potential [73]. This may be partially due to 
the fact NaOCl dissolves necrotic tissue more effectively than vital tissue [41]. 
Like all endodontic irrigants, NaOCl use should be confined within the root canal 
system to avoid the rare complication of a sodium hypochlorite accident. This 
occurs when NaOCl is extruded outside of the tooth into surrounding tissues. The 
resulting host response can manifest as local edema or mild ecchymosis only to 
severe extensive mediastinal ecchymosis. While unpleasant, sodium 
hypochlorite accidents are rare and almost never life threatening and the benefits 
of using NaOCl as an endodontic irrigant far outweigh this risk [74]. While 
precautions must be considered in the use of NaOCl, it fulfills more of the desired 
characteristics proposed for an ideal irrigant than current alternatives and is 
recommended as the main irrigant in endodontics. However, Buttler et al. 
reported that 0.58% to 5.20% NaOCl does not detoxify E. coli LPS [75]. Lipids 
that contain saturated fatty acids will not react with NaOCl, leaving the possibility 
for continued virulence if this is the only irrigant used. 
Calcium hydroxide is a slow acting intracanal medicament that is widely 
used in endodontics for its antimicrobial activity, tissue dissolving capacity, 
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inhibition of tooth resorption, and induction of hard tissue repair [11, 33]. It is a 
mildly water-soluble white powder with highly alkaline pH of 12.5. Calcium 
hydroxide slowly dissociates into calcium and hydroxyl ions when in an aqueous 
environment [76]. The hydroxyl ions are extremely active ions that are thought to 
damage bacterial membranes, denature proteins, and damage bacterial DNA 
when in direct contact [11]. Hermann first introduced calcium hydroxide for use in 
dentistry in 1920 [77]. Sjögren showed calcium hydroxide is ineffective as an 
intracanal disinfectant with an application time of only 10 minutes, but an 
application time of 7 days effectively removed cultivable bacteria that had 
survived mechanical instrumentation of the canal [12]. Due to its slow acting 
nature, calcium hydroxide is most commonly used in endodontics as an 
interappointment canal medicament. Previous studies have reported the toxic 
LPS Lipid A molecule is hydrolyzed into innocuous fatty acids and amino sugars 
by calcium hydroxide, discontinuing LPS activity in vitro. It is the only endodontic 
irrigant or medicament shown to inactivate the negative effects of LPS [13, 31, 
78, 79]. Calcium hydroxide has a very important role in endodontic therapy, but 
compared to NaOCl it has a limited antimicrobial spectrum and is not active 
against all endodontic microbiota. It also cannot reliably eliminate bacteria from 
the inside of dentinal tubules due to its physical properties and lack of flow. 
Calcium hydroxide should always be used clinically in combination with other 
irrigants and medicaments [11].  
Chlorhexidine is a synthetic cationic bisbiguanide with two symmetric 4-
chlorophenyl rings and two biguanide groups connected by a central 
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hexamethylene chain [80]. It is available in varying concentrations in solution and 
gel forms. This antimicrobial agent is lipophilic and hydrophobic and interacts 
with negatively charged phosphate groups on microbial cell walls to increase 
permeability and to allow for penetration of the chlorhexidine molecule into the 
cell [81]. In very low concentrations it is bacteriostatic and will cause leakage of 
cellular contents like phosphorus and potassium. At high concentrations it has a 
bactericidal effect by coagulating the cellular cytoplasm, causing cell death. It is 
effective against Gram negative and Gram positive bacteria, yeast, fungi, and 
select viruses including herpes, cytomegalovirus, and HIV [82]. The use of 
chlorhexidine was first introduced in medicine in 1954 for debriding skin, mucous 
membranes, and wounds. It was reported for oral use in 1959 to control dental 
bacterial plaque and became more commonly used in dentistry in the 1970s [82]. 
When used as an antimicrobial intracanal medicament, chlorhexidine has been 
shown to be as effective or more effective than calcium hydroxide [83, 84]. Liquid 
concentrations of 0.2% to 2% have been shown to have similar antimicrobial 
activity as 5.25% NaOCl [85, 86]. However, unlike NaOCl, chlorhexidine is 
unable to dissolve vital or necrotic tissue [87] and its effect on microbial biofilms 
is significantly lesser than NaOCl [81]. In the root canal, positively charged 
chlorhexidine adsorbs onto dentin and maintains continued antimicrobial action 
on the dentin surface beyond the time the medication is applied in a feature 
called substantivity. White et al. showed the substantivity of 2% chlorhexidine 
solution lasted for 72 hours after endodontic irrigation [88] and Rosenthal et al. 
showed the substantivity lasted for up to 12 weeks [89]. Allergy to chlorhexidine 
 18 
is very rare. Other side effects such as contact dermatitis and dysgeusia are 
uncommon and seem to be dose dependent. Chlorhexidine is highly 
biocompatible [81]. Previous bacterial lipid studies have shown chlorhexidine has 
little to no effect on inactivating the Lipid A portion of LPS and does not 
adequately reduce remaining LPS in the root canal system after 
chemomechanical preparation [82].  
The removal and degradation of P. endodontalis Lipid 654 with intracanal 
irrigants and medicaments may hinder the progression of apical periodontitis in 
endodontic infections. Lipid 654 produced from P. endodontalis and P. gingivalis 
is structurally identical [6]. The effect of NaOCl at different concentrations and 
calcium hydroxide on Lipid 654 is not fully understood. We examined the 
capacity of these substances to remove Lipid 654 produced from P. gingivalis 
from mineralized surfaces and the capacity for chemical degradation of Lipid 654 
to the Lipid 430 form.  
 
 
Materials and Methods: 
For this investigation, Lipid 654 was prepared from P. gingivalis using HPLC 
as previously described [90]. Briefly, P. gingivalis was grown in pure culture 
followed by extraction of lipids and purification of the Lipid 654 preparation as 
described below. 
 
 Bacterial growth- Bacteria were grown in broth culture as previously 
described.  P. gingivalis  (ATCC #33277, type strain) was inoculated into basal 
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(peptone, trypticase and yeast extract) medium supplemented with hemin and 
menadione (Sigma-Aldrich) and brain heart infusion [90].  Culture purity was 
verified by Gram stain, lack of growth in aerobic culture and formation of uniform 
colonies when inoculated on brain heart infusion agar plates and grown under 
anaerobic conditions. The suspension cultures were incubated for four days in an 
anaerobic chamber flushed with N2 (80%), CO2 (10%) and H2 (10%) at 37°C and 
the bacteria were harvested by centrifugation (2000 x g for 2 hour).  
 
Lipid extraction, fractionation and characterization- Lipids were extracted from 
lyophilized bacterial pellets.   Generally 2 to 4g of bacterial pellet was extracted 
for each semipreparative fractionation.  The bacterial samples were weighed and 
dissolved in chloroform:methanol:water (1.33:2.67,1, v/v/v, 2g of bacterial pellet 
in a total of 20 ml of solvent) as previously described [90].  The mixture was 
vortexed at 15 min intervals for 2 hours and the mixture was supplemented with 6 
ml of chloroform and 6 ml of (2N KCl + 0.5N K2HPO4).  The mixture was vortexed 
and centrifuged (2000 x g) at 20°C for 4 h.  The lower organic phase was 
removed and dried under nitrogen.  The dried extract was reconstituted in HPLC 
solvent (hexane:isopropanol:water, 6:8:0.75, v/v/v, 24 ml) and vortexed [90].  The 
sample was centrifuged at 2500 x g for 10 minutes and the supernatant removed 
for HPLC analysis.  Semipreparative HPLC fractionation was accomplished using 
a Shimadzu HPLC system equipped with dual pumps (LC-10ADvp), automated 
controller (SCL-10Avp) and in line UV detector (SPD-10Avp).  Lipids were 
fractionated using normal phase isocratic separation (Ascentis®Si, 25 cm x 10 
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um, Supelco Analytical) with a solvent flow of 1.8 ml/min and 1 min
um, Supelco Analytical) interfaced with
these were used to calculate the recovery of Lipid 654 on the discs as well as the 
conversion of Lipid 654 to Lipid 430 on the discs.   
 
Statistical Analysis- Since the results typically were not normally distributed, 
data are expressed using Box-Whisker plots.  Statistical testing included Analysis 
of Variance (ANOVA) with pairwise comparisons using the Scheffe test. For data 
sets that did not satisfy a normal distribution test, the results were depicted as 
Box Whisker plots and either Kruskal-Wallace or Mann Whitney U rank order 
tests were applied.  A p value of <0.05 was considered to be significant 
 
Results: 
Analysis of P. gingivalis Lipid 654 extracts treated with sterile water, 
calcium hydroxide in a saturated sterile water solution, 0.5% NaOCl, and 5.25% 
NaOCl for 1 minute, 15 minutes, or 1-week intervals revealed these 
medicaments do impact the amount of Lipid 654 and Lipid 430 recovered after 
treatment. Lipid 654 recovery from the bovine dentin discs after treatment is 
illustrated in Figure 5.   
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 Figure 5. Lipid 654 recovered from bovine dentin discs after exposure to sterile 
water, calcium hydroxide (Ca(OH)2) in a saturated sterile water solution, 0.5% 
NaOCl, and 5.25% NaOCl for 1 minute, 15 minute, or one week intervals. 
 
More Lipid 654 was recovered from the bovine dentin discs in the positive 
control of lipid alone versus any other treatment group. This finding was highly 
significant (p<0.01) in all cases except for the comparison between lipid alone 
and calcium hydroxide treatment for 1 minute. Less Lipid 654 was recovered 
from bovine dentin discs of the negative control samples in the disc alone group 
when compared to all other treatment groups except for 5.25% NaOCl at both 1 
and 15 minute exposures. Less Lipid 654 was recovered from the 5.25% NaOCl 
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1 and 15 minute exposure groups than the disc alone negative control, but these 
differences were not significant. 
There was no difference in recovery of Lipid 654 or Lipid 430 by 0.5% 
NaOCl compared to 5.25% NaOCl for any time of exposure. The 0.5% and 
5.25% NaOCl treatment groups at both 1 and 15 minutes had significantly less 
remaining Lipid 654 than calcium hydroxide treatment for corresponding 1 or 15 
minutes exposure periods (p<0.05). However, all NaOCl groups acted similarly to 
calcium hydroxide exposure for 1 week for Lipid 654 recovery. There was no 
significant difference in any of the NaOCl treatment groups for Lipid 654 recovery 
when compared to 1 week of calcium hydroxide treatment.  
The difference in Lipid 654 and Lipid 430 recovery between 1 minute and 
15 minute exposure times was not significant for the control groups of lipid alone 
or bovine dentin disc alone. Exposure time of 1 minute compared to 15 minutes 
had no impact on amount of Lipid 645 or Lipid 430 recovered from the bovine 
dentin discs after treatment with 0.5% NaOCl, 5.25% NaOCl, or sterile water. No 
significant difference was found in the recovery of Lipid 654 for calcium hydroxide 
treatment for 15 minutes versus 1 week, but samples for both fifteen minute and 
1 week exposure times had significantly less lipid recovery than exposure for 1 
minute (p<0.05).  
Lipid 430 is a breakdown product of Lipid 654 after hydrolysis of the ester-
linked fatty acid. Unlike Lipid 654, it is soluble in neutral or basic aqueous 
environments [30]. Figure 6 shows the recovered Lipid 430 for each treatment 
group. More Lipid 430 was recovered from bovine dentin discs treated with 
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calcium hydroxide for 1 week than all other treatment groups and this difference 
was significant for all comparisons except for calcium hydroxide exposure for 1 
week versus treatment with calcium hydroxide for 1 minute or lipid alone for 15 
minutes (p<0.05). Time of exposure did have an impact on treatment with 
calcium hydroxide. In the recovery of Lipid 430, no significant difference was 
found between calcium hydroxide treatment for 1 minute versus 15 minutes or 1 
week, but significantly more lipid was recovered with calcium hydroxide treatment 
for 1 week compared to 15 minutes (p<0.05). 
 
 
 
 
Figure 6. Lipid 430 recovered from bovine dentin discs after exposure to sterile 
water, calcium hydroxide (Ca(OH)2) in a saturated sterile water solution, 0.5% 
NaOCl, and 5.25% NaOCl for 1 minute, 15 minute, or 1 week intervals. 
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Figure 7 shows the ratio of recovered Lipid 430 versus Lipid 654 for each 
experimental group as determined using mass spectrometry. The highest ratio 
was observed with the Lipid 654 applied to bovine dentin discs exposed to 
calcium hydroxide for 1 week. These results suggest an increased conversion of 
Lipid 654 to Lipid 430 in this group compared to the other groups.  
 
 
Figure 7. Ratio of Lipid 430 to Lipid 654 recovered from bovine dentin discs after 
exposure to sterile water, calcium hydroxide (Ca(OH)2) in a saturated sterile 
water solution, 0.5% NaOCl, and 5.25% NaOCl for 1 minute, 15 minute, or 1 
week intervals. 
 
 
 
Discussion: 
Our study demonstrated that Lipid 654 from P. gingivalis can be reliably 
removed from bovine dentin discs with common endodontic irrigants and 
medicaments and that Lipid 654 is hydrolyzed into the Lipid 430 form when 
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exposed to calcium hydroxide for the duration of 1 week. Because the structure 
of Lipid 654 and Lipid 430 produced from P. gingivalis and P. endodontalis is 
identical, we believe that these lipid classes isolated from P. endodontalis will 
respond in a similar manner to such treatment.  
In a clinical study, Endo et al. reported higher levels of LPS in infected root 
canals were related to larger size of associated radiolucent lesions in the 
periapical bone[91]. Gomes et al. described similar findings when they found 
positive correlations between higher LPS levels in primary and secondary 
endodontic infections and size of the associated radiolucent lesion and higher 
LPS levels in primary infections and increased clinical symptoms[92]. They called 
for establishment of clinical protocols focused on the neutralization and 
elimination of not only Gram negative bacteria, but also their harmful byproducts, 
in endodontic therapy. 
Similarly, Lipid 654 has been shown to promote inflammatory and bone 
cell activation processes that may lead to apical periodontitis [6]. This 
underscores the importance of removal of Lipid 654 in endodontics clinically. 
Members of the Bacteroidetes phylum are the major producers of Lipid 654. 
Bacteroidetes make up almost half of the gastrointestinal microorganisms and 
are also common in periodontal disease. Serine lipids specifically have been 
recovered in diseased periodontal tissues and serum [30].  
Our study demonstrates that Lipid 654 is effectively removed from bovine 
dentin discs by 0.5% NaOCl and 5.25% NaOCl after as little as 1 minute 
exposure time and by calcium hydroxide after 1 week of exposure. The 
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concentration of NaOCl from diluted 0.5% to full strength 5.25% did not 
significantly impact lipid removal capability. NaOCl is significantly more effective 
at removing Lipid 654 from bovine dentin discs when compared to calcium 
hydroxide at identical 1 or 15 minute exposure times, but acts similarly to calcium 
hydroxide exposure of 1 week.  
The bovine dentin discs used in this study contained a baseline amount of 
detectable lipid, as can be seen in the analysis of the disc alone treatment 
groups. Less Lipid 654 was recovered from negative control samples of the 
bovine disc alone when compared to all other treatment groups except for 5.25% 
NaOCl at both 1 and 15 minute exposures. However, this finding was not 
statistically significant. This suggests the 5.25% NaOCl not only removed the 
Lipid 654 that was applied experimentally, but possibly also baseline lipid that 
already existed in these bovine dentin discs. 
 We found Lipid 654 is hydrolyzed to the Lipid 430 form when treated with 
calcium hydroxide for 1 week. In a study of the ability of common endodontic 
irrigants and calcium hydroxide to break down bacterial LPS, Buck et al. 
demonstrated that alkaline solutions degrade LPS more effectively than acidic 
and that exposure of LPS to calcium hydroxide for two and five days caused 
more degradation than exposure for only 1 day [21]. Our results regarding Lipid 
654 correspond with these findings. The breakdown product Lipid 430 class has 
been shown to be significantly biologically active with the ability to inhibit 
osteoblast differentiation gene expression in cells from wild type mice, but shows 
only slight activity in cells from TLR2 knock out mice. This suggests Lipid 430 
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affects osteoblast differentiation with cell activation events, and is not fully 
dependent on engagement with TLR2 [Nemati et al., submitted]. Lipid 430 is 
recovered at a much lower rate than Lipid 654 in lipid extracts from P. gingivalis 
[30], but is recovered in higher quantities from P. gingivalis lipid extracts of 
chronically inflamed tissue from diseased periodontium. Additionally, Lipid 430 
has been found to be biologically active at levels four to tenfold lower than those 
of Lipid 654 [Wang et al., submitted]. This accentuates the importance of 
removing both Lipid 654 and Lipid 430 clinically, not simply hydrolyzing the 
former to the latter. Lipid 430 is soluble in neutral or basic aqueous environments 
while Lipid 654 is not water soluble unless sonicated [30]. Therefore, Lipid 430 
may be more easily removed by endodontic solutions clinically than Lipid 654. 
The removal of Lipid 654 versus Lipid 430 by endodontic irrigants and 
medicaments requires further study. In unpublished studies we evaluated the 
ability of calcium hydroxide to alter the biologic activity of serine bacterial lipids. 
We found calcium hydroxide treatment de-esterified Lipid 654 and significantly 
reduced its effect on the release of the inflammation mediator tumor necrosis 
factor alpha. 
The exact amount of time needed for calcium hydroxide to kill bacteria 
clinically is not known. In an in vivo study, Sjögren showed exposing 
chemomechanically debrided necrotic pulps to calcium hydroxide for only 10 
minutes resulted in elimination of cultivable bacteria in half of the experimental 
cases while a 7 day exposure resulted in elimination of cultivable bacteria from 
all experimental samples[12]. Therefore, long-term application of calcium 
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hydroxide has been suggested as an interappointment dressing to destroy 
bacteria that may survive initial chemomechanical preparation of the canal and is 
an argument for two-visit treatment of necrotic pulps. There is ample evidence 
that a bacteria-free status cannot be achieved in a chemomechanically prepared 
necrotic pulp space after 1 endodontic treatment visit [93, 94]. However, multiple 
studies have not found a significant difference in outcome between 1 visit 
treatment compared to 2 visit treatment with calcium hydroxide interappointment 
dressing in teeth with necrotic pulps [95-97]. Because bacterial lipids have been 
shown to be active well after cell death [21], it is possible that removal and 
degradation of these lipids are important considerations in addition to achieving 
bacteria-free status of the prepared canal. Our study supports the use of calcium 
hydroxide as a long-term intracanal medicament for the purpose of removing 
Lipid 654 from the canal and also degrading it to the Lipid 430 form.  
In summary, the results of our study demonstrate the ability of NaOCl at 
0.5% and 5.25% concentrations and long-term 1 week calcium hydroxide 
treatment to remove  P. gingivalis Lipid 654 from bovine dentin discs. We also 
demonstrate that long-term 1 week calcium hydroxide treatment can hydrolyze P. 
gingivalis Lipid 654 into the Lipid 430 form.  
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